中药复方通过调节口腔细菌与真菌平衡治疗特发性膜性肾病
本研究纳入24例特发性膜性肾病患者(白苔11例、黄苔13例)及10名健康人,采用中药复方肾妙方治疗,用全长16S rRNA和ITS测序检测治疗前后口腔细菌与真菌。结果显示肾妙方对黄苔患者疗效更显著,黄苔富集弯曲杆菌,韦荣球菌A的富集可能部分解释疗效,马拉色菌在肾妙方治疗后减少。
要点
- 肾妙方对黄苔特发性膜性肾病患者疗效优于白苔患者。
- 口腔弯曲杆菌可能是黄苔的生物标志物,韦荣球菌A富集与疗效相关。
- 肾妙方通过调节口腔真菌与细菌动态平衡治疗特发性膜性肾病。
核心结论
- 肾妙方通过调节口腔真菌与细菌的动态平衡有助于治疗特发性膜性肾病。
- 黄苔患者使用肾妙方的疗效比白苔患者更显著。
研究设计与样本
- 研究纳入24例特发性膜性肾病患者(白苔11例、黄苔13例)和10名健康人,患者接受肾妙方治疗。
- 采用全长16S rRNA和ITS基因测序检测治疗前后口腔细菌组与真菌组。
主要发现
- 黄苔患者口腔弯曲杆菌富集,可能作为黄苔的生物标志物。
- 韦荣球菌A的富集可能部分解释肾妙方的疗效。
- 马拉色菌在肾妙方治疗后减少。
- 特发性膜性肾病患者口腔真菌-细菌相互作用高度复杂且动态变化。
关键数值与推荐
- 肾妙方对黄苔患者的疗效比白苔患者更显著。
- 黄苔患者口腔富集弯曲杆菌,韦荣球菌A富集与疗效相关,马拉色菌经肾妙方治疗后减少。
临床怎么用
- 临床可参考舌苔颜色评估特发性膜性肾病患者对肾妙方的潜在疗效。
- 口腔微生物组特征(如弯曲杆菌、韦荣球菌A、马拉色菌)可能作为个体化治疗的参考指标。
局限性
- 研究样本量较小,仅纳入24例患者和10名健康人。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Moshen Fuyuan Formula (MSFY) is one of the representative Chinese medicine compound for Idiopathic membranous nephropathy (IMN), that originate from Fang Ji Huang Qi decoction in the Han dynasty. IMN is usually accompanied by different tongue coatings in traditional Chinese medicine (TCM), and tongue microorganisms are important factors affecting the formation of the tongue coating. Recently, oral microbiomes, including bacteria and fungi, have been identified as pivotal factors that contribute to disease development. However, the regulation of oral microbiomes by MSFY has not been defined. AIM OF THE STUDY: In this work, we explore the characteristics of oral bacteria and fungi in IMN patients with different tongue coatings, and clarify the therapeutic effect of MSFY based on oral microbiome. MATERIALS AND METHODS: We enrolled 24 patients with IMN, including 11 with white tongue (IMN-W) and 13 with yellow tongue (IMN-Y), and recruited an additional 10 healthy individuals. Patients with IMN were treated with the MSFY. The oral bacteriome and fungi before and after treatment were detected using full-length 16S rRNA and internal transcribed spacer gene sequencing. RESULTS: The therapeutic effect of MSFY on patients with yellow tongue coating was more significant than that on patients with white tongue coating. In terms of oral bacteriome, Campylobacter bacteria were enriched in patients with yellow tongue and could be a promising biomarker for yellow coating. Enrichment of Veillonella parvula_A may partially account for the therapeutic effect of MSFY. As for oral fungi, Malassezia globosa was enhanced in patients with IMN-W and reduced in patients with IMN-Y. Notably, it was reduced by MSFY. We also found that mycobiome-bacteriome interactions were highly complex and dynamic in patients with IMN. CONCLUSION: The regulation of the dynamic balance between oral fungi and bacteria by MSFY contributes to the treatment of IMN. This study determined the oral bacteriome and mycobiome of patients with IMN with different tongue coatings before and after MSFY treatment, which aids in promoting personalized treatment in clinical TCM and provides direction for investigating the mechanism of Chinese herbal medicines.
引用
- Wang XH, Yang YN, Li YH, et al. Oral bacteriome and mycobiome of patients with idiopathic membranous nephropathy with different tongue coatings treated with a Chinese herbal formula. J Ethnopharmacol. 2024. PMID: 38685365. doi:10.1016/j.jep.2024.118233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。